Withdrawn from the sale a known cure for hypertension – ElSol.com.ar – Diario de Mendoza, Argentina

Through a medical alert, the National Administration of Drugs, Foods and Medical Technologies (Anmat) announced that it ordered the withdrawal of the sale of more than 300 batches of drugs with the drug valsartan, indicated to treat hypertension and reduce the risk of stroke or stroke.

The regulatory authority provided a list of the number of antihypertensive lots of seven local laboratories whose active substance was contaminated with N-nitrosodimethylamine (NDMA), a substance. which can cause cancer. The product comes from a laboratory in China

Over the past two weeks, the European Medicines Agency (EMA), the United States Food and Drug Administration (FDA) and the authorities of La Public Health in Canada issued similar alerts, which were subsequently replicated by regulators in the region, such as Colombia and Bolivia.

Anmat recommends that patients treated with any of these lots do not discontinue treatment and consult your GP on how to act. You can also call the free number 0800-333-1234, Monday to Friday from 8am to 8pm, Saturdays, Sundays and public holidays from 10am to 6pm, or send an e-mail to [email protected] [19659005] These are the Argentinian laboratories informed by ANMAT of the active ingredient questioned.